Alpha-lifetech · Newsroom

Alpha Lifetech-Overview of High Throughput Screening (HTS)
High Throughput Screening is a transformative technology that has revolutionized the fields of drug discovery, genomics, and biotechnology.

January 3, 2025

Alpha Lifetech-Naïve Antibody Library Overview
Alpha Lifetech can offer naïve antibody libraries from non-immunized animals and humans based on our mature phage display technology.

December 21, 2024

Alpha Lifetech-Llama Antibody Structure
Hundreds of Llama antibody library construction services are successfully delivered every year. Alpha Lifetech has established a comprehensive and mature phage display technology service platform.

December 12, 2024

Alpha Lifetech-Fab Fragment of Antibody
Now Alpha Lifetech's antibody discovery R&D team is proud to announce that we can develop a synthesized Fab library with independent clones over 10^11.

December 6, 2024

Alpha Lifetech-Drug Discovery High Throughput Screening
Alpha Lifetech has a comprehensive M13/T7 phage display platform to ensure the construction and screening of antibody libraries. we can provide high-throughput screening

November 28, 2024

Alpha Lifetech-Antibody Screening and Identification
Antibody screening and identification are critical processes in the development of monoclonal and polyclonal antibodies for research, diagnostic, and therapeutic purposes. Alpha Lifetech can provide antibody screening.

November 21, 2024

Alpha Lifetech-Advantages of Phage Display
Phage display is a powerful and versatile technology used to study protein interactions, identify binding partners, and engineer novel proteins and antibodies. Alpha Lifetech can provide Phage Display Technology

November 15, 2024

Understanding Humanized Antibody Therapy: Advancing Precision Medicine -Alpha Lifetech
Alpha Lifetech can provide antibody humanization service

May 9, 2024

Alpha Lifetech’s Innovative Path in Therapeutics
Alpha Lifetech, our commitment to innovation in therapeutic proteins has led us to focus on the potential of nanobodies — tiny yet mighty proteins derived from llama antibodies.

April 19, 2024